VERTEX PHARMACEUTICALS INC (VRTX) Stock Analyst Earnings Estimates
NASDAQ:VRTX - Nasdaq - US92532F1003 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 8.931B 17.91% | 9.869B 10.51% | 11.02B 11.66% | 12.166B 10.40% | 13.459B 10.63% | 14.72B 9.37% | 16.34B 11.01% | 18.045B 10.43% | 20.05B 11.11% | 21.264B 6.05% | 23.536B 10.68% | |
| EBITDA YoY % growth | 4.584B 57.66% | 4.54B -0.96% | 4.603B 1.37% | 5.52B 19.93% | 6.705B 21.47% | 7.408B 10.48% | 7.883B 6.41% | 8.766B 11.20% | 9.552B 8.97% | 10.197B 6.75% | 11.682B 14.56% | |
| EBIT YoY % growth | 4.436B 59.44% | 4.359B -1.73% | 4.396B 0.84% | 5.397B 22.78% | 6.377B 18.16% | 7.111B 11.51% | 7.852B 10.42% | 8.933B 13.77% | 9.844B 10.20% | 10.374B 5.38% | 11.562B 11.45% | |
| Operating Margin | 49.67% | 44.17% | 39.89% | 44.36% | 47.38% | 48.31% | 48.05% | 49.50% | 49.10% | 48.79% | 49.12% | |
| EPS YoY % growth | 14.89 14.36% | 15.22 2.22% | 0.29 -98.09% | 18.30 6,211.74% | 21.10 15.30% | 23.41 10.93% | 25.90 10.64% | 29.96 15.67% | 32.68 9.09% | 34.73 6.28% | 39.39 13.39% |
All data in USD
| Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|---|
| EPS Q2Q % growth | 4.70 7.32% | 5.15 29.29% | 5.11 25.95% | 4.98 10.27% | 5.07 7.84% | 5.10 -0.82% |
| Revenue Q2Q % growth | 3.105B 12.02% | 3.289B 12.95% | 3.166B 14.29% | 3.191B 7.63% | 3.261B 5.02% | 3.325B 1.09% |
| EBITDA Q2Q % growth | 1.427B 10.45% | 1.627B 23.19% | 1.739B 61.42% | 1.509B 15.46% | 1.471B 3.08% | 1.397B -14.14% |
| EBIT Q2Q % growth | 1.379B 21.90% | 1.524B 36.87% | 1.541B 49.77% | 1.453B 25.99% | 1.487B 7.83% | 1.495B -1.90% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | 4.52 135.23% | 4.35 | 0.17 | 3.98% |
| Q1 2025 Q2Q % growth | 4.06 -14.71% | 4.37 | -0.31 | -7.20% |
| Q4 2024 Q2Q % growth | 3.98 -5.24% | 4.11 | -0.13 | -3.07% |
| Q3 2024 Q2Q % growth | 4.38 7.35% | 4.22 | 0.16 | 3.69% |
| Q2 2024 Q2Q % growth | -12.83 -429.82% | 3.00 | -15.83 | -527.57% |
| Q1 2024 Q2Q % growth | 4.76 56.07% | 4.14 | 0.62 | 14.85% |
| Q4 2023 Q2Q % growth | 4.20 11.70% | 4.18 | 0.02 | 0.36% |
| Q3 2023 Q2Q % growth | 4.08 1.75% | 4.05 | 0.03 | 0.66% |
| Q2 2023 Q2Q % growth | 3.89 8.06% | 3.96 | -0.07 | -1.75% |
| Q1 2023 Q2Q % growth | 3.05 -13.35% | 3.06 | -0.01 | -0.21% |
| Q4 2022 Q2Q % growth | 3.76 11.57% | 3.58 | 0.18 | 4.95% |
| Q3 2022 Q2Q % growth | 4.01 12.64% | 3.72 | 0.29 | 7.89% |
| Q2 2022 Q2Q % growth | 3.60 15.76% | 3.55 | 0.05 | 1.44% |
| Q1 2022 Q2Q % growth | 3.52 18.12% | 3.56 | -0.04 | -1.18% |
| Q4 2021 Q2Q % growth | 3.37 34.26% | 3.37 | 0.00 | 0.13% |
| Q3 2021 Q2Q % growth | 3.56 34.85% | 3.14 | 0.42 | 13.27% |
| Q2 2021 Q2Q % growth | 3.11 19.16% | 2.56 | 0.55 | 21.59% |
| Q1 2021 Q2Q % growth | 2.98 16.41% | 2.74 | 0.24 | 8.66% |
| Q4 2020 Q2Q % growth | 2.51 47.65% | 2.64 | -0.13 | -5.00% |
| Q3 2020 Q2Q % growth | 2.64 114.63% | 2.39 | 0.25 | 10.49% |
| Q2 2020 Q2Q % growth | 2.61 107.14% | 2.12 | 0.49 | 23.38% |
| Q1 2020 Q2Q % growth | 2.56 124.56% | 1.88 | 0.68 | 36.03% |
| Q4 2019 Q2Q % growth | 1.70 | 1.23 | 0.47 | 38.03% |
| Q3 2019 Q2Q % growth | 1.23 | 1.17 | 0.06 | 4.95% |
| Q2 2019 Q2Q % growth | 1.26 | 1.09 | 0.17 | 15.76% |
| Q1 2019 Q2Q % growth | 1.14 | 0.99 | 0.15 | 14.85% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | 2.965B 12.06% | 2.964B | 700K | 0.02% |
| Q1 2025 Q2Q % growth | 2.77B 2.96% | 2.91B | -139.8M | -4.80% |
| Q4 2024 Q2Q % growth | 2.912B 15.66% | 2.836B | 76M | 2.68% |
| Q3 2024 Q2Q % growth | 2.772B 11.61% | 2.778B | -6.1M | -0.22% |
| Q2 2024 Q2Q % growth | 2.646B 6.11% | 2.715B | -69.4M | -2.56% |
| Q1 2024 Q2Q % growth | 2.691B 13.30% | 2.63B | 60.6M | 2.30% |
| Q4 2023 Q2Q % growth | 2.518B 9.34% | 2.564B | -46.3M | -1.81% |
| Q3 2023 Q2Q % growth | 2.484B 6.39% | 2.55B | -66.5M | -2.61% |
| Q2 2023 Q2Q % growth | 2.493B 13.52% | 2.468B | 25.2M | 1.02% |
| Q1 2023 Q2Q % growth | 2.375B 13.22% | 2.384B | -9.2M | -0.39% |
| Q4 2022 Q2Q % growth | 2.303B 11.10% | 2.347B | -44.3M | -1.89% |
| Q3 2022 Q2Q % growth | 2.334B 17.65% | 2.271B | 63.3M | 2.79% |
| Q2 2022 Q2Q % growth | 2.196B 22.46% | 2.175B | 21.2M | 0.97% |
| Q1 2022 Q2Q % growth | 2.098B 21.64% | 2.118B | -20.5M | -0.97% |
| Q4 2021 Q2Q % growth | 2.073B 27.32% | 2.043B | 29.561M | 1.45% |
| Q3 2021 Q2Q % growth | 1.984B 28.99% | 1.893B | 91.164M | 4.82% |
| Q2 2021 Q2Q % growth | 1.793B 17.64% | 1.752B | 41.37M | 2.36% |
| Q1 2021 Q2Q % growth | 1.724B 13.81% | 1.69B | 34.305M | 2.03% |
| Q4 2020 Q2Q % growth | 1.628B 15.18% | 1.616B | 11.82M | 0.73% |
| Q3 2020 Q2Q % growth | 1.538B 61.95% | 1.515B | 23.271M | 1.54% |
| Q2 2020 Q2Q % growth | 1.524B 61.96% | 1.413B | 111.485M | 7.89% |
| Q1 2020 Q2Q % growth | 1.515B 76.50% | 1.313B | 202.107M | 15.39% |
| Q4 2019 Q2Q % growth | 1.413B | 1.033B | 380.265M | 36.81% |
| Q3 2019 Q2Q % growth | 949.828M | 969.92M | -20.092M | -2.07% |
| Q2 2019 Q2Q % growth | 941.293M | 903.29M | 38.003M | 4.21% |
| Q1 2019 Q2Q % growth | 858.435M | 867.48M | -9.045M | -1.04% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | -0.4% | -1.82% | -0.11% | -0.84% |
| Revenue | 0.17% | -0.03% | -0.07% | -0.34% |